Pfizer Stock News

Antiemetics are medications that work for vomiting and nausea. Antiemetics are commonly used to treat motion sickness and opioid pain relievers, general anesthetics, and side effects of chemotherapy for cancer. The Global Antiemetics Industry Report is an in-depth study analyzing

The minimum period to get a booster shot after taking two doses of the Pfizer/BioNTech, Moderna or AstraZeneca vaccine, or the Johnson & Johnson single-dose, will be five months instead of six, according to a letter published Tuesday by the

In a third day of grueling testimony, Elizabeth Holmes expressed regret for putting a Pfizer company logo on some validation documents sent to Walgreens, even though Pfizer never validated Theranos.

Elizabeth Holmes confessed that she added the Pfizer and Schering-Plough logos to memos given to investors. But problems virtually everywhere else in the company werent her fault, she said.

VICTORIA Children in British Columbia five to 11 years old will soon have access to Pfizers COVID-19 pediatric vaccine. The pediatric COVID-19 vaccine directly protects children and will mean less disruption to the activities that are important to them, such as school, sports and social events, said Dr. Bonnie Henry, provincial health officer. Once []

The Boone County Health Dept., after going multiple weeks without pediatric doses of Pfizers COVID-19 vaccine, has received an additional shipment and has

Children in British Columbia five to 11 years old will soon have access to Pfizers COVID-19 pediatric vaccine.

Pfizer for 5-11 will be available at the Finning Cat drive-thru at 391 Hwy 16

Northwest Quadrant Wealth Management LLC reduced its position in Pfizer Inc. (NYSE:PFE) by 7.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,908 shares of the biopharmaceutical companys stock after selling 391 shares during the quarter. Northwest Quadrant Wealth Management LLCs holdings in []

EUROPE is battling a blazing Covid outbreak again because it shunned the AstraZeneca jab, the vaccine-maker claims. CEO Pascal Soriot said the companys vaccine gives deeper, longer-lasting protection than those by Pfizer and Moderna. He claimed it gives a bigger boost to T cell immunity, training white blood cells to seek out and destroy cells []

Elizabeth Holmes told the jury in her criminal fraud trial on Tuesday that she personally put the letterhead of pharma giants Pfizer and Schering-Plough on documents sent to potential business partners and investors without the companies'' consent. It was the most damning admission Holmes has made under oath in three days of testifying in her own defense. The former CEO of the blood-testing company Theranos is attempting to persuade the jury that she is innocent of 11 counts of fraud and conspiracy to commit fraud. Prosecutors have said Holmes forged multiple reports to give the impression that the pharmaceutical companies were endorsing Theranos devices, when in reality they had distanced themselves from the startup. Holmes said she hadn''t intended to deceive anyone but was merely attempting to acknowledge other work Theranos had done with the pharma companies. Still, it was a mistake, she said. "I wish I''d done it differently," said Holmes, speaking behind a plexiglass-enclosed witness box in a calm and confident tone.

Public health says there are about 10,500 children aged five to 11 in Guelph that are eligible for Pfizer''s COVID-19 vaccine.

In her third day defending herself on the witness stand against criminal fraud charges, Theranos founder Elizabeth Holmes testified that she was responsible for putting logos from pharmaceutical companies on Theranos reports without authorization, telling jurors, ‘”I wish I had done it differently.” The pilfered logos from pharma giants Pfizer and Schering-Plough, slapped onto Theranos […]

DT Investment Partners LLC boosted its holdings in shares of Pfizer Inc. (NYSE:PFE) by 42.4% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 34,844 shares of the biopharmaceutical companys stock after purchasing an additional 10,377 shares during the quarter. DT Investment Partners LLCs holdings in Pfizer were worth $1,499,000 as of its most []

Pfizer, Inc. (NYSE: PFE ) found huge success with its COVID-19 franchise that includes Comirnaty, the COVID-19 vaccine it co-developed with BioNTech SE (NASDAQ: BNTX ), and its yet-to-be authorized oral COVID-19 pill Paxlovid. The Pfizer Analyst: SVB Leerink analyst Geoffrey Porges reiterated a Market Perform rating on Pfizer shares and increased the price target from $48 to $52. The Pfizer Thesis: Pfizer''s top line will exceed $100 billion in 2022 compared to $82 billion this year thanks to incremental revenue contributions from Comirnaty and Paxlovid, Porges said in a note. Paxlovid revenue is likely to come in at $95 million in 2021, rising to $24 billion in 2022 and $33 billion in 2023, the analyst said. Purchases of Paxlovid will be large, with Pfizer having already bagged a $5.3-billion contract from the U.S., Porges said. Revenues from the antiviral will be profitable, he added. Related Link: The Daily Biotech Pulse: Arrowhead Out-Licenses NASH Drug, Tonix Touts COVID-19 Treatment Data,